Advanced search
Publication Cover
Expert Review of Vaccines Volume 12, 2013 - Issue 8
Submit an article Journal homepage
595
Views
30
CrossRef citations to date
0
Altmetric
Editorial

Matrix-M™ adjuvant: enhancing immune responses by ‘setting the stage’ for the antigen

Karin Lövgren Bengtsson Isconova AB, Kungsgatan 109, SE-75318 Uppsala, Sweden. [email protected]
,
Karin H Karlsson Isconova AB, Kungsgatan 109, SE-75318 Uppsala, Sweden
,
Sofia E Magnusson Isconova AB, Kungsgatan 109, SE-75318 Uppsala, Sweden
,
Jenny M Reimer Isconova AB, Kungsgatan 109, SE-75318 Uppsala, Sweden
&
Linda Stertman Isconova AB, Kungsgatan 109, SE-75318 Uppsala, Sweden
Pages 821-823 | Published online: 09 Jan 2014

References

  • Morein B, K Lovgren-Bengtsson, J Cox. Modern adjuvants, functional aspects. In: Concepts in Vaccine Development. Kaufmann SHE (Ed.). Walter de Gruyter, Berlin, Germany, 243–263 (1996).
  • Singh M, Chakrapani A, O’Hagan D. Nanoparticles and microparticles as vaccine-delivery systems. Expert Rev. Vaccines 6(5), 797–808 (2007).
  • Allison AC, Byars NE. Syntex adjuvant formulation. Res. Immunol. 143(5), 519–525 (1992).
  • Morein F, Bengtsson KL. Functional aspects of iscoms. Immunol. Cell Biol. 76(4), 295–299 (1998).
  • Morein B, Sundquist B, Höglund S, Dalsgaard K, Osterhaus A. Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses. Nature 308(5958), 457–460 (1984).
  • Takahashi H, Takeshita T, Morein B, Putney S, Germain RN, Berzofsky JA. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 344(6269), 873–875 (1990).
  • Lövgren K, Morein B. The requirement of lipids for the formation of immunostimulating complexes (ISCOMS). Biotechnol. Appl. Biochem. 10(2), 161–172 (1988).
  • Lovgren Bengtsson K, Morein B, Osterhaus AD. ISCOM technology-based Matrix M adjuvant: success in future vaccines relies on formulation. Expert Rev. Vaccines 10(4), 401–403 (2011).
  • Cox RJ, Pedersen G, Madhun AS et al. Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a Phase I clinical trial. Vaccine 29(45), 8049–8059 (2011).
  • Pedersen GK, Madhun AS, Breakwell L et al. T-helper 1 cells elicited by H5N1 vaccination predict seroprotection. J. Infect. Dis. 206(2), 158–166 (2012).
  • O’Hagan DT, Ott GS, De Gregorio E, Seubert A. The mechanism of action of MF59 – an innately attractive adjuvant formulation. Vaccine 30(29), 4341–4348 (2012).
  • Cahill RN, Frost H, Trnka Z. The effects of antigen on the migration of recirculating lymphocytes through single lymph nodes. J. Exp. Med. 143(4), 870–888 (1976).
  • Windon RG, Chaplin PJ, Beezum L et al. Induction of lymphocyte recruitment in the absence of a detectable immune response. Vaccine 19(4-5), 572–578 (2000).
  • Reimer JM, Karlsson KH, Lövgren-Bengtsson K, Magnusson SE, Fuentes A, Stertman L. Matrix-M™ adjuvant induces local recruitment, activation and maturation of central immune cells in absence of antigen. PLoS ONE 7(7), e41451 (2012).
  • Magnusson SE, Reimer JM, Karlsson KH, Lilja L, Bengtsson KL, Stertman L. Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice. Vaccine 31(13), 1725–1733 (2013).
  • Neeland MR, Meeusen EN, de Veer MJ. Afferent lymphatic cannulation as a model system to study innate immune responses to infection and vaccination. Vet. Immunol. Immunopathol. (2013).
  • Oppenheim JJ, Tewary P, de la Rosa G, Yang D. Alarmins initiate host defense. Adv. Exp. Med. Biol. 601), 185–194 (2007).
  • Yang D, Oppenheim JJ. Alarmins and antimicrobial immunity. Med. Mycol. 47(Suppl. 1), S146–S153 (2009).
  • Yang D, de la Rosa G, Tewary P, Oppenheim JJ. Alarmins link neutrophils and dendritic cells. Trends Immunol. 30(11), 531–537 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.